Improving tests for abnormal cervical cells after menopause
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial is looking at better ways to diagnose changes in the cervix in women after menopause. It may help by improving how doctors decide which cervical abnormalities need attention and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are postmenopausal (no vaginal bleeding for at least 1 year) and age 50 or older
- You are being referred for a colposcopy because of a positive HPV test and/or an abnormal Pap (cervical cytology) result
- You may qualify if you previously had abnormal cervical biopsy results and it has been at least 6 months since your last colposcopy with biopsies
- You have not used estrogen in the last 3 months (any form)
- You have not had prior radiation therapy to the cervix, and you have not had cervical removal procedures like amputation or cone biopsy
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
This trial is testing a new screening tool (ELEVATE) to see how well it works in detecting cervical precancer. If you have an abnormal pap smear or a positive HPV test and are scheduled for a colposcopy, you may be able to help validate this tool.
This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.
This study follows women who are newly diagnosed with cervical or endometrial (uterine lining) cancer at a health check-up. It helps doctors learn more about these cancers and how they behave, which may improve future care.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.